Category: Drug safety and pharmacovigilance

In this comprehensive blog post, we explore into the concept of temporal relationships within pharmacovigilance, particularly focusing on assessing causality. The discussion includes important insights and illustrative examples to enhance understanding.

This blog refers to the importance of risk management in pharmacovigilance and explore its definitions and significance. We highlight how a robust risk management plan plays a vital role in ensuring the safety and effectiveness of pharmaceutical products.

In this pharmacovigilance blog, where we delve deep in to understanding E2b, the definitions and meanings and why is it important consideration in pharmacovigilance. Contrary to common misconceptions that perceive E2B as an error format, we unveil its true nature and significance.

In this comprehensive blog, we delve into reported special scenarios within the realm of pharmacovigilance. Our exploration encompasses detailed definitions of each scenario and outlines typical situations associated with them.

In this comprehensive blog, you’ll uncover key information about what “Day Zero” signifies in the context of case processing and the broader field of pharmacovigilance. Additionally, you’ll gain insights into calculating the day of submissions.

In this detailed blog post, we explore into the intricate differences between the terms “dechallenge” and “rechallenge,” providing key considerations. Learn deeper by clicking here.

In this comprehensive blog, we delve into why reporting adverse events is crucial for public safety and discuss the concerning issue of the rapid and widespread lack of adverse event reports.

In this article we explore in to the difference between the terms drug safety and pharmacovigilance. While many of us thinking both are interchangeable, they actually have a distinct meaning. So you land on the right place to clarify and gain knowledge about it.